WHO Suspends Indian-developed Shan5 Combination Vaccine

by Trilok Kapur on  March 19, 2010 at 11:40 AM Drug News
RSS Email Print This Page Comment
Font : A-A+

The Indian-developed Shan5 combination vaccine, which is used against infections such as diphtheria, tetanus and hepatitis B, was suspended by The World Health Organization on Thursday.
 WHO Suspends Indian-developed Shan5 Combination Vaccine
WHO Suspends Indian-developed Shan5 Combination Vaccine

"The manufacturer got some complaints that there was suspended white sediment in some of the vials," WHO spokeswoman Alison Brunier told AFP.

As a result, the UN health agency decided to suspend the use of the vaccine, procured by UN Children's Fund (UNICEF) and used in countries such as Chad, Colombia and Pakistan.

"None of the information suggests that there is a safety problem. This is more of a precautionary measure," said Brunier.

She added that the vaccines have been "quarantined in the countries" and have not been recalled by the manufacturer, Shantha Biotechnics India, a subsidiary of French pharmaceutical giant Sanofi-Aventis.

Shantha had won a 340 million dollar contract from UNICEF in September to provide the vaccine, which is also used against pertussis and haemophilus influenza B.

Between January 2009 and February 2010, about 23.9 million doses of the vaccine were supplied, the WHO said.

Source: AFP
TRI

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive